Biodiversity Intervention and Atopic Sensitization
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Allergic Rhinitis
- Allergic Sensitisation
- Allergy
- Atopy
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The study consists of two arms, the intervention arm and the placebo arm. Children are randomized into the arms.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Double-blind randomized trialPrimary Purpose: Prevention
Participation Requirements
- Age
- Younger than 1 years
- Gender
- Both males and females
Description
Newborns will start to be exposed to biodiversity intervention or placebo at the age of two months. The proof of concept trial will be double blind. Intervention will start at the age of 2 months and it will end when children become 12 months old. Children will be randomized to the two arms. IgE sen...
Newborns will start to be exposed to biodiversity intervention or placebo at the age of two months. The proof of concept trial will be double blind. Intervention will start at the age of 2 months and it will end when children become 12 months old. Children will be randomized to the two arms. IgE sensitization is the primary outcome at the age of two and three years.
Tracking Information
- NCT #
- NCT03872219
- Collaborators
- Tampere University
- Pirkanmaa Hospital District (Pirkanmaan sairaanhoitopiiri)
- Business Finland (National Innovation Agency)
- Investigators
- Not Provided
Get Well Soon